首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1774356

全球血小板市場

Global Blood Platelet Market

出版日期: 2025年07月08日 | 出版商:

BCC Research | 英文 136 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計全球血小板市場規模將從2025年的32億美元成長到 2,030年底的40億美元，預測期內的年複合成長率為 4.6%。

預計北美市場將從2025年的11億美元成長到2030年底的13億美元，預測期間的年複合成長率為3.8%。預計歐洲市場將從2025年的9.405億美元成長到2030年底的12億美元，預測期間的年複合成長率為4.7%。

本報告調查了全球血小板市場，並提供了市場概況摘要、市場影響因素和市場機會分析、市場規模趨勢和預測以及各個細分市場和地區的詳細分析。

有關捐血的關鍵統計資料
適合捐血血小板的血型
血小板捐獻流程
波特五力分析
宏觀經濟因素分析
經濟成長與醫療費用支出
世界人口老化
政府法規和衛生政策
全球疾病負擔
通貨膨脹和捐血服務成本上升
美國關稅對血小板市場的影響

第3章市場動態

市場動態
市場促進因素
增加手術程序
加深對捐血重要性的認知
加強政府力度
慢性血液疾病的盛行率
市場限制
血小板輸注過程中感染風險增加
血小板輸注費用高昂
血小板供應鏈與物流挑戰
捐血短缺
市場機會
再生醫學和生物技術中捐血血小板的應用日益廣泛
新興市場的需求和不斷擴大的醫療基礎設施

第4章監管情況

血小板市場的監管洞察

第5章新興技術

概述
新興技術
血小板採集病原體減少技術進展
血小板儲存系統的開發
將人工智慧和自動化融入血液採集和處理

第6章市場區隔分析

細分市場
市場細分：依血小板類型
關鍵要點
單採血小板
全血來源的血小板
市場區隔：依應用
關鍵要點
癌症治療
外科手術
治療慢性疾病
創傷
血小板減少性疾病（非癌性）
血小板功能障礙
市場區隔：依最終用戶
關鍵要點
醫院和診所
門診手術中心
血庫和輸血中心
研究實驗室
癌症治療中心
其他
地理分佈
市場區隔：依地區
關鍵要點
北美洲
歐洲
亞太地區
南美洲
中東和非洲

第7章競爭訊息

關鍵要點
競爭格局
世界主要組織列表
關鍵發展和策略
夥伴關係與合作
拓展業務和服務
技術開發
監管和法律發展

第8章環境、社會與管治（ESG）視角

ESG：簡介
血小板市場的永續性
BCC的結語

第9章附錄

調查方法
參考
簡稱
公司簡介
AABB - ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
AMERICA'S BLOOD CENTERS
AUSTRALIAN RED CROSS LIFEBLOOD
BELGIAN RED CROSS-FLANDERS
BLOOD BANK OF ALASKA
BLOOD CENTERS OF AMERICA
CANADIAN BLOOD SERVICES
EUROPEAN BLOOD ALLIANCE
FINNISH RED CROSS BLOOD SERVICE
INDIAN RED CROSS SOCIETY
JAPANESE RED CROSS SOCIETY
ONEBLOOD
SANBS
THE AMERICAN NATIONAL RED CROSS
VITALANT

簡介目錄圖表

Product Code: BIO268A

The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.

The North American market for blood platelets is expected to grow from $1.1 billion in 2025 and is projected to reach $1.3 billion by the end of 2030, at a CAGR of 3.8% during the forecast period of 2025 to 2030.

The European market for blood platelets is expected to grow from $940.5 million in 2025 and is projected to reach $1.2 billion by the end of 2030, at a CAGR of 4.7% during the forecast period of 2025 to 2030.

Report Scope

The report provides an overview of the global blood platelet market and analyzes market trends. It includes global revenue ($ million) for base year 2024, estimates for 2025 and a forecast period through 2030. The market is segmented based on platelet type, application, end user and region. The regions covered in this study include North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, focusing on major countries in these regions.

The report examines the significant trends and challenges that affect the market and blood donation landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report provides an in-depth analysis of the global blood platelets market, with a comprehensive evaluation of the value chain from blood platelets collection to end-use applications. The scope encompasses the activities of blood collection organizations, which are responsible for the voluntary collection of blood donations in each country. These organizations play a critical role in separating, processing and storing platelets from donated blood and ensuring their timely and safe distribution to various healthcare settings.

The market analysis covers the distribution of collected blood platelets to various end users, including hospitals, clinics, ambulatory surgical centers, cancer treatment centers, blood banks and transfusion centers. These facilities use blood platelets for multiple clinical and therapeutic purposes.

The report also examines the operational models of independent and government-funded organizations while also analyzing regulatory frameworks related to platelet donation, safety protocols and distribution standards across the market.

The report concludes with an analysis of the competitive landscape, providing a list of key organizations in the global blood platelet market. It also includes a dedicated section of company profiles that outlines details about leading market enterprises.

Report Includes

45 data tables and 53 additional tables
Overview and analysis of the global market for blood platelets, also known as thrombocytes
Analyses of global market trends, with revenue data for 2022-2024, estimates for 2025, and projected CAGRs through 2030
Estimates of the size and revenue prospects for the global blood platelet market, along with a market share analysis by platelet type, application, end-user, and region
Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, government policies and regulations and the impacts of macroeconomic variables
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
An assessment of the current market environment, innovation and prospects, emerging technologies, new developments, and products in the pipeline
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudes
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of the leading companies, including American National Red Cross, Vitalant, Canadian Blood Services, NHS Blood and Transplant, and Red Cross Society of China

Chapter 1 Executive Summary

Market Outlook
Scope of the Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Introduction
Key Statistics About Blood Donations
Blood Types Suitable for Platelet Donations
Platelet Donation Process
Porter's Five Forces Analysis
Threat of New Entrants (Moderate to High)
Bargaining Power of Suppliers (Moderate)
Bargaining Power of Buyers (Moderate to High)
Threat of Substitutes (Very Low)
Level of Competitiveness (Moderate)
Macroeconomic Factor Analysis
Economic Growth and Healthcare Spending
An Aging Population Worldwide
Government Regulations and Health Policies
Global Disease Burden
Rising Inflation and Cost of Blood Donation Services
Impact of Ongoing Tariffs Imposed by the U.S. on the Blood Platelet Market

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Increased Number of Surgical Procedures
Better Awareness of the Importance of Blood Donations
Rising Government Initiatives
Prevalence of Chronic Blood-Related Disorders
Market Restraints
Elevated Risk of Infection in Platelet Transfusion Procedures
High Cost of Platelet Transfusions
Challenges in Blood Platelet Supply Chain and Logistics
Shortage of Blood Donors
Market Opportunities
Increased Use of Donated Blood Platelets in Regenerative Medicine and Biotechnology
Demand from Emerging Markets and Expanding Healthcare Infrastructure

Chapter 4 Regulatory Landscape

Regulatory Insights into the Blood Platelet Market

Chapter 5 Emerging Technologies

Overview
Emerging Technologies
Advances in Pathogen Reduction Techniques for Platelet Collection
Developments in Platelet Storage Systems
Integration of AI and Automation in Blood Collection and Processing

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown by Platelet Type
Key Takeaways
Apheresis-Derived Platelets
Whole Blood-Derived Platelets
Market Breakdown by Application
Key Takeaways
Cancer Treatment
Surgical Procedures
Chronic Disease Treatment
Traumatic Injury
Thrombocytopenia (Non-Cancer Related)
Platelet Function Disorder
Market Breakdown by End User
Key Takeaways
Hospitals and Clinics
Ambulatory Surgical Centers
Blood Banks and Transfusion Centers
Research Laboratories
Cancer Treatment Centers
Others
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Landscape
List of Leading Organizations Across the Globe
Key Developments and Strategies
Partnerships and Collaborations
Business and Service Expansions
Technological Developments
Regulatory and Legal Developments

Chapter 8 Environmental, Social and Governance (ESG) Perspective

Introduction to ESG
Sustainability in the Blood Platelet Market
Concluding Remarks from BCC

Chapter 9 Appendix

Research Methodology
References
Abbreviations
Company Profiles
AABB - ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
AMERICA'S BLOOD CENTERS
AUSTRALIAN RED CROSS LIFEBLOOD
BELGIAN RED CROSS-FLANDERS
BLOOD BANK OF ALASKA
BLOOD CENTERS OF AMERICA
CANADIAN BLOOD SERVICES
EUROPEAN BLOOD ALLIANCE
FINNISH RED CROSS BLOOD SERVICE
INDIAN RED CROSS SOCIETY
JAPANESE RED CROSS SOCIETY
ONEBLOOD
SANBS
THE AMERICAN NATIONAL RED CROSS
VITALANT

簡介目錄圖表

List of Tables

Summary Table : Global Market for Blood Platelets, by Region, Through 2030
Table 1 : Platelet Use by Patients in the U.S., 2024
Table 2 : Prevalence of Each Blood Type Among the U.S. Population, by Blood Type, 2024
Table 3 : Prevalence of Each Blood Type Among the U.S. Population, by Race, 2024
Table 4 : Tests Used in the U.S. to Screen Donated Blood
Table 5 : Risk of Acquiring Infectious Disease Through Blood Transfusions
Table 6 : Comparison Between Whole Blood-Derived and Apheresis-Derived Platelets
Table 7 : Porter's Five Forces: Rating Scale
Table 8 : Viral Infections and Their Transmission Risks in Blood Transfusions
Table 9 : Regulatory Landscape Governing Blood Platelets, by Country
Table 10 : Global Market for Blood Platelets, by Platelet Type, Through 2030
Table 11 : Global Market for Apheresis-Derived Platelets, by Region, Through 2030
Table 12 : Global Market for Whole Blood-Derived Platelets, by Region, Through 2030
Table 13 : Global Market for Blood Platelets, by Application, Through 2030
Table 14 : Global Market for Blood Platelets in Cancer Treatment, by Region, Through 2030
Table 15 : Global Market for Blood Platelets in Surgical Procedures, by Region, Through 2030
Table 16 : Global Market for Blood Platelets in Chronic Disease Treatment, by Region, Through 2030
Table 17 : Global Market for Blood Platelets in Traumatic Injuries, by Region, Through 2030
Table 18 : Global Market for Blood Platelets in Thrombocytopenia (Non-Cancer Related) Treatment, by Region, Through 2030
Table 19 : Global Market for Blood Platelets in Platelet Function Disorder Treatment, by Region, Through 2030
Table 20 : Global Market for Blood Platelets, by End User, Through 2030
Table 21 : Global Market for Blood Platelets in Hospitals and Clinics, by Region, Through 2030
Table 22 : Global Market for Blood Platelets in Ambulatory Surgical Centers, by Region, Through 2030
Table 23 : Global Market for Blood Platelets in Blood Banks and Transfusion Centers, by Region, Through 2030
Table 24 : Global Market for Blood Platelets in Research Laboratories, by Region, Through 2030
Table 25 : Global Market for Blood Platelets in Cancer Treatment Centers, by Region, Through 2030
Table 26 : Global Market for Blood Platelets in Other End Users, by Region, Through 2030
Table 27 : Global Market for Blood Platelets, by Region, Through 2030
Table 28 : North American Market for Blood Platelets, by Country, Through 2030
Table 29 : North American Market for Blood Platelets, by Platelet Type, Through 2030
Table 30 : North American Market for Blood Platelets, by Application, Through 2030
Table 31 : North American Market for Blood Platelets, by End User, Through 2030
Table 32 : European Market for Blood Platelets, by Country, Through 2030
Table 33 : European Market for Blood Platelets, by Platelet Type, Through 2030
Table 34 : European Market for Blood Platelets, by Application, Through 2030
Table 35 : European Market for Blood Platelets, by End User, Through 2030
Table 36 : Asia-Pacific Market for Blood Platelets, by Country, Through 2030
Table 37 : Asia-Pacific Market for Blood Platelets, by Platelet Type, Through 2030
Table 38 : Asia-Pacific Market for Blood Platelets, by Application, Through 2030
Table 39 : Asia-Pacific Market for Blood Platelets, by End User, Through 2030
Table 40 : South American Market for Blood Platelets, by Country, Through 2030
Table 41 : South American Market for Blood Platelets, by Platelet Type, Through 2030
Table 42 : South American Market for Blood Platelets, by Application, Through 2030
Table 43 : South American Market for Blood Platelets, by End User, Through 2030
Table 44 : MEA Market for Blood Platelets, by Subregion, Through 2030
Table 45 : MEA Market for Blood Platelets, by Platelet Type, Through 2030
Table 46 : MEA Market for Blood Platelets, by Application, Through 2030
Table 47 : MEA Market for Blood Platelets, by End User, Through 2030
Table 48 : Key Providers of Blood Platelets, 2024
Table 49 : Key Partnerships and Collaborations in the Blood Platelet Market, 2024
Table 50 : Business Expansions in the Blood Platelet Market, 2023-2025
Table 51 : Technological Developments in the Blood Platelets Market, 2023
Table 52 : Key Regulatory and Legal Developments in the Blood Platelet Market, 2023
Table 53 : Sustainability Initiatives by Key Organizations, 2023 and 2024
Table 54 : Abbreviations Used in the Report
Table 55 : AABB - Association for the Advancement of Blood & Biotherapies: Company Snapshot
Table 56 : AABB - Association for the Advancement of Blood & Biotherapies: Product Portfolio
Table 57 : AABB - Association for the Advancement of Blood & Biotherapies: News/Key Developments, 2023
Table 58 : America's Blood Centers: Company Snapshot
Table 59 : America's Blood Centers: Product Portfolio
Table 60 : Australian Red Cross Lifeblood: Company Snapshot
Table 61 : Australian Red Cross Lifeblood: Financial Performance, FY 2022 and 2023
Table 62 : Australian Red Cross Lifeblood: Product Portfolio
Table 63 : Australian Red Cross Lifeblood: News/Key Developments, 2023 and 2024
Table 64 : Belgian Red Cross-Flanders: Company Snapshot
Table 65 : Belgian Red Cross-Flanders: Product Portfolio
Table 66 : Belgian Red Cross-Flanders: News/Key Developments, 2024
Table 67 : Blood Bank of Alaska: Company Snapshot
Table 68 : Blood Bank of Alaska: Product Portfolio
Table 69 : Blood Centers of America: Company Snapshot
Table 70 : Blood Centers of America: Product Portfolio
Table 71 : Blood Centers of America: News/Key Developments, 2023 and 2024
Table 72 : Canadian Blood Services: Company Snapshot
Table 73 : Canadian Blood Services: Financial Performance, FY 2022 and 2023
Table 74 : Canadian Blood Services: Product Portfolio
Table 75 : Canadian Blood Services: News/Key Developments, 2025
Table 76 : European Blood Alliance: Company Snapshot
Table 77 : European Blood Alliance: Product Portfolio
Table 78 : Finnish Red Cross Blood Service: Company Snapshot
Table 79 : Finnish Red Cross Blood Service: Financial Performance, FY 2023 and 2024
Table 80 : Finnish Red Cross Blood Service: Product Portfolio
Table 81 : Finnish Red Cross Blood Service: News/Key Developments, 2023-2025
Table 82 : Indian Red Cross Society: Company Snapshot
Table 83 : Indian Red Cross Society: Product Portfolio
Table 84 : Japanese Red Cross Society: Company Snapshot
Table 85 : Japanese Red Cross Society: Product Portfolio
Table 86 : OneBlood: Company Snapshot
Table 87 : OneBlood: Product Portfolio
Table 88 : OneBlood: News/Key Developments, 2023
Table 89 : SANBS: Company Snapshot
Table 90 : SANBS: Financial Performance, FY 2022 and 2023
Table 91 : SANBS: Product Portfolio
Table 92 : The American National Red Cross: Company Snapshot
Table 93 : The American National Red Cross: Product Portfolio
Table 94 : The American National Red Cross: News/Key Developments, 2024-2025
Table 95 : Vitalant: Company Snapshot
Table 96 : Vitalant: Product Portfolio
Table 97 : Vitalant: News/Key Developments, 2023

List of Figures

Summary Figure : Global Market Shares of Blood Platelets, by Region, 2024
Figure 1 : Insights and Statistics on Blood Donations
Figure 2 : Journey of Whole Blood-Derived Platelets
Figure 3 : Porter's Five Forces Analysis of the Global Blood Platelet Market
Figure 4 : Snapshot of the Dynamics of the Blood Platelet Market
Figure 5 : Organ Transplant Procedures Performed, by Organ Type, 2023
Figure 6 : Emerging Technologies in the Blood Platelet Market
Figure 7 : Global Market Shares of Blood Platelets, by Platelet Type, 2024
Figure 8 : Advantages of Apheresis-Derived Platelets
Figure 9 : Global Market Shares of Apheresis-Derived Platelets, by Region, 2024
Figure 10 : Global Market Shares of Whole Blood-Derived Platelets, by Region, 2024
Figure 11 : Global Market Shares of Blood Platelets, by Application, 2024
Figure 12 : Global Market Shares of Blood Platelets in Cancer Treatment, by Region, 2024
Figure 13 : Global Market Shares of Blood Platelets in Surgical Procedures, by Region, 2024
Figure 14 : Global Market Shares of Blood Platelets in Chronic Disease Treatment, by Region, 2024
Figure 15 : Global Market Shares of Blood Platelets in Traumatic Injuries, by Region, 2024
Figure 16 : Global Market Shares of Blood Platelets in Thrombocytopenia (Non-Cancer Related) Treatment, by Region, 2030
Figure 17 : Global Market Shares of Blood Platelets in Platelet Function Disorder Treatment, by Region, 2030
Figure 18 : Global Market Shares of Blood Platelets, by End User, 2024
Figure 19 : Global Market Shares of Blood Platelets in Hospitals and Clinics, by Region, 2024
Figure 20 : Global Market Shares of Blood Platelets in Ambulatory Surgical Centers, by Region, 2024
Figure 21 : Global Market Shares of Blood Platelets in Blood Banks and Transfusion Centers, by Region, 2024
Figure 22 : Global Market Shares of Blood Platelets in Research Laboratories, by Region, 2024
Figure 23 : Global Market Shares of Blood Platelets in Cancer Treatment Centers, by Region, 2024
Figure 24 : Global Market Shares of Blood Platelets in Other End Users, by Region, 2024
Figure 25 : Global Market Shares of Blood Platelets, by Region, 2024
Figure 26 : Snapshot of the ESG Pillars
Figure 27 : Australian Red Cross Lifeblood: Revenue Shares, by Business Segment, FY 2023
Figure 28 : Canadian Blood Services: Revenue Shares, by Business Segment, FY 2023
Figure 29 : Finnish Red Cross Blood Service: Revenue Shares, by Business Segment, FY 2024